Schizophrenia.com

Minerva Neurosciences to Host R&D Day Focused on Unmet Needs and Emerging Treatment Strategies in Schizophrenia

everhopeful February 21, 2017, 4:23pm 2

Haha! I actually beat you to it today!

Topic		Replies	Views	Activity
Minerva Neurosciences Announces Completion of Development and Final Selection of Once-Daily Dose Formulation of MIN-101 for Its Schizophrenia Program News	0	313	December 3, 2014
Minerva Neurosciences Reports First Quarter 2017 Financial Results and Business Updates News	2	700	May 4, 2017
Minerva Neurosciences’ Clinical Data Featured at The American College of Neuropsychopharmacology Annual Meeting News	2	562	December 5, 2016
MIN-101 phase 2b, results due in Q4 News	0	536	September 27, 2016
Minerva Neurosciences to Host R&D Day Focused on Unmet Needs News	2	797	February 21, 2017